Preparation method of nalbuphine free alkali

A synthesis method and compound technology, which are applied in the field of medicinal chemistry and organic synthesis, can solve the problem that the product is difficult to realize industrial production, and achieve the effect of reducing the content and improving the yield.

Inactive Publication Date: 2020-05-08
扬子江药业集团江苏紫龙药业有限公司
View PDF6 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] For example: in US Patent US740531, γ-MnO is used 2 Photocatalytic synthesis of nalbuphine, although the use of photocatalysts avoids the use of highly toxic reagents cyanogen bromide and expensive vinyl chloroformate, but its disadvantage is that the resulting products are difficult to achieve industrial production through chromatographic column separation
In U.S. Patent No. 3,332,950, lithium aluminum hydride is used as a reducing agent, but the product after reduction still contains 10% of the 6-position hydroxyl β isomer, and sodium borohydride is used in the synthesis process of nalbuphine hydrochloride announced by Zheng Huazhang et al. As a reducing agent, but its nalbuphine free base reduction yield is only 75%, and there are still 6-hydroxyl β-isomers

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of nalbuphine free alkali
  • Preparation method of nalbuphine free alkali
  • Preparation method of nalbuphine free alkali

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] In a 100 mL three-neck flask, add 1.01 g of compound II and 40 mL of absolute ethanol, stir, and control the reaction temperature to 0°C. Weigh 719 mg (1.2 eq) of sodium triacetoxyborohydride, add it to the reaction system in batches, and take samples for control every 1 h until the reaction of compound II is complete. After the reaction was finished, add 2 mL of water to quench the reaction, concentrate under reduced pressure with a rotary evaporator to remove ethanol, add saturated sodium carbonate solution to adjust the pH to about 9.0, add 10 mL of water, extract 3 times with 10 mL of ethyl acetate, collect the organic phase, and use Wash with saturated sodium chloride, add 2 g of anhydrous sodium sulfate to dry, spin dry and concentrate to obtain 0.87 g of nalbuphine free base, yield 86.0%, purity 99.01%, β-nalbuphine content=0.45%.

Embodiment 2

[0020] In a 100 mL three-necked flask, add 1.03 g of compound II and 40 mL of absolute ethanol, stir, and control the reaction temperature to 70°C. Weigh 611 mg (1.0 eq) of sodium triacetoxyborohydride, add it to the reaction system in batches, and take samples for control every 1 h until the reaction of Compound II is complete. After the reaction was finished, add 2 mL of water to quench the reaction, concentrate under reduced pressure with a rotary evaporator to remove ethanol, add saturated sodium carbonate solution to adjust the pH to about 9.0, add 10 mL of water, extract 3 times with 10 mL of ethyl acetate, collect the organic phase, and use Wash with saturated sodium chloride, add 2 g of anhydrous sodium sulfate to dry, spin dry and concentrate to obtain 0.78 g of nalbuphine free base, yield 75.70%, purity 99.12%, β-nalbuphine content=0.38%.

Embodiment 3

[0022] In a 100 mL three-neck flask, add 1.05 g of compound II and 40 mL of anhydrous methanol, stir, and control the reaction temperature to -20°C. Weigh 2.49g (4.0eq) of sodium triacetoxyborohydride, add it to the reaction system in batches, and take samples for control every 1h until the reaction of compound II is completed. After the reaction was finished, add 2 mL of water to quench the reaction, concentrate under reduced pressure with a rotary evaporator to remove methanol, add saturated sodium carbonate solution to adjust the pH to about 9.0, add 10 mL of water, extract 3 times with 10 mL of ethyl acetate, collect the organic phase, and then use Wash with saturated sodium chloride, add 2 g of anhydrous sodium sulfate to dry, spin dry and concentrate to obtain 0.76 g of nalbuphine free base with a yield of 72.4%, a purity of 99.03%, and a content of β-nalbuphine=0.52%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a preparation method of nalbuphine free alkali, i.e., (-)-17-(cyclobutylmethyl)-4,5alpha-epoxymorphine-3,6alpha,14-hydroxyl. A synthetic route of the preparation method is shown in the specification. According to the novel method, a new reduction reaction condition is adopted, so the purity of nalbuphine free alkali in a reduction product reaches 99%, and the problems of excessive generation of 6-beta isomers of the reduction product and difficulty in purification of the free alkali are avoided.

Description

technical field [0001] The invention relates to the field of medicinal chemistry and organic synthesis, in particular to the preparation of nalbuphine free base (-)-17-(cyclobutanemethyl)-4,5α-epoxymorphine-3,6α,14-hydroxyl method. Background technique [0002] Nalbuphine hydrochloride is a morphine-like central analgesic with minimal addiction and can be used for the analgesic treatment of moderate to severe pain caused by various diseases. It has high safety and is a second-class psychotropic drug. Nalbuphine hydrochloride has low side effects in terms of spirit, sympathomimetic, and respiratory depression. It has been used as an adjuvant drug for anesthesia in foreign countries for preoperative and postoperative analgesia and obstetrical pain during production and delivery. It is widely used. The drug was synthesized for the first time in 1965 by DuPont of the United States, and the original manufacturer was Hospira. Nalbuphine Hydrochloride (Nalbuphine Hydrochloride), ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & AuthorityApplications(China)
IPC IPC(8): C07D489/02
CPCC07D489/02
Inventor朱顺戴志成潘瀛鹏成玲
Owner扬子江药业集团江苏紫龙药业有限公司